Mohamed, E.M.;                     Dharani, S.;                     Nutan, M.T.H.;                     Cook, P.;                     Arunagiri, R.;                     Khan, M.A.;                     Rahman, Z.    
        Application of Sucrose Acetate Isobutyrate in Development of Co-Amorphous Formulations of Tacrolimus for Bioavailability Enhancement. Pharmaceutics 2023, 15, 1442.
    https://doi.org/10.3390/pharmaceutics15051442
    AMA Style
    
                                Mohamed EM,                                 Dharani S,                                 Nutan MTH,                                 Cook P,                                 Arunagiri R,                                 Khan MA,                                 Rahman Z.        
                Application of Sucrose Acetate Isobutyrate in Development of Co-Amorphous Formulations of Tacrolimus for Bioavailability Enhancement. Pharmaceutics. 2023; 15(5):1442.
        https://doi.org/10.3390/pharmaceutics15051442
    
    Chicago/Turabian Style
    
                                Mohamed, Eman M.,                                 Sathish Dharani,                                 Mohammad T. H. Nutan,                                 Phillip Cook,                                 Rajendran Arunagiri,                                 Mansoor A. Khan,                                 and Ziyaur Rahman.        
                2023. "Application of Sucrose Acetate Isobutyrate in Development of Co-Amorphous Formulations of Tacrolimus for Bioavailability Enhancement" Pharmaceutics 15, no. 5: 1442.
        https://doi.org/10.3390/pharmaceutics15051442
    
    APA Style
    
                                Mohamed, E. M.,                                 Dharani, S.,                                 Nutan, M. T. H.,                                 Cook, P.,                                 Arunagiri, R.,                                 Khan, M. A.,                                 & Rahman, Z.        
        
        (2023). Application of Sucrose Acetate Isobutyrate in Development of Co-Amorphous Formulations of Tacrolimus for Bioavailability Enhancement. Pharmaceutics, 15(5), 1442.
        https://doi.org/10.3390/pharmaceutics15051442